Use of cardiac magnetic resonance to assess viability

Anja Wagner; Heiko Mahrholdt; Raymond J. Kim; Robert M. Judd

doi:10.1007/s11886-005-0012-8

Use of cardiac magnetic resonance to assess viability

Anja Wagner, Heiko Mahrholdt, Raymond J. Kim, Robert M. Judd

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The accurate differentiation of viable and nonviable myocardium is crucial for therapy planning in patients with coronary artery disease and left ventricular dysfunction. Traditional techniques such as echocardiography, positron emission tomography, single photon emission computed tomography, and dobutamine echocardiography have established roles. Cardiac MRI (CMR) is a rapidly emerging new modality that is used at an increasing number of medical centers in Europe and the United States. This review describes the role of CMR for the assessment of myocardial viability in the setting of acute and chronic ischernic ventricular dysfunction.

Original language	English (US)
Pages (from-to)	59-64
Number of pages	6
Journal	Current Cardiology Reports
Volume	7
Issue number	1
DOIs	https://doi.org/10.1007/s11886-005-0012-8
State	Published - Jan 2005
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11886-005-0012-8

Cite this

@article{a105198d04e949f991af82d27505986b,

title = "Use of cardiac magnetic resonance to assess viability",

abstract = "The accurate differentiation of viable and nonviable myocardium is crucial for therapy planning in patients with coronary artery disease and left ventricular dysfunction. Traditional techniques such as echocardiography, positron emission tomography, single photon emission computed tomography, and dobutamine echocardiography have established roles. Cardiac MRI (CMR) is a rapidly emerging new modality that is used at an increasing number of medical centers in Europe and the United States. This review describes the role of CMR for the assessment of myocardial viability in the setting of acute and chronic ischernic ventricular dysfunction.",

author = "Anja Wagner and Heiko Mahrholdt and Kim, {Raymond J.} and Judd, {Robert M.}",

note = "Funding Information: This work was supported in part by National Institutes of Health-National Heart, Lung and Blood Institute RO1-HL63268 (RMJ), K02-HL04394 (RMJ), and RO1-HL64726 (RJK).",

year = "2005",

month = jan,

doi = "10.1007/s11886-005-0012-8",

language = "English (US)",

volume = "7",

pages = "59--64",

journal = "Current Cardiology Reports",

issn = "1523-3782",

publisher = "Current Medicine Group",

number = "1",

}

TY - JOUR

T1 - Use of cardiac magnetic resonance to assess viability

AU - Wagner, Anja

AU - Mahrholdt, Heiko

AU - Kim, Raymond J.

AU - Judd, Robert M.

N1 - Funding Information: This work was supported in part by National Institutes of Health-National Heart, Lung and Blood Institute RO1-HL63268 (RMJ), K02-HL04394 (RMJ), and RO1-HL64726 (RJK).

PY - 2005/1

Y1 - 2005/1

N2 - The accurate differentiation of viable and nonviable myocardium is crucial for therapy planning in patients with coronary artery disease and left ventricular dysfunction. Traditional techniques such as echocardiography, positron emission tomography, single photon emission computed tomography, and dobutamine echocardiography have established roles. Cardiac MRI (CMR) is a rapidly emerging new modality that is used at an increasing number of medical centers in Europe and the United States. This review describes the role of CMR for the assessment of myocardial viability in the setting of acute and chronic ischernic ventricular dysfunction.

AB - The accurate differentiation of viable and nonviable myocardium is crucial for therapy planning in patients with coronary artery disease and left ventricular dysfunction. Traditional techniques such as echocardiography, positron emission tomography, single photon emission computed tomography, and dobutamine echocardiography have established roles. Cardiac MRI (CMR) is a rapidly emerging new modality that is used at an increasing number of medical centers in Europe and the United States. This review describes the role of CMR for the assessment of myocardial viability in the setting of acute and chronic ischernic ventricular dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=13544272022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544272022&partnerID=8YFLogxK

U2 - 10.1007/s11886-005-0012-8

DO - 10.1007/s11886-005-0012-8

M3 - Review article

C2 - 15610650

AN - SCOPUS:13544272022

SN - 1523-3782

VL - 7

SP - 59

EP - 64

JO - Current Cardiology Reports

JF - Current Cardiology Reports

IS - 1

ER -

Use of cardiac magnetic resonance to assess viability

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this